コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 o 8 h after injection (10-fold elevation 4 h postinjection).
2 preinjection vs 0.18 +/- 0.10 mu m/s, n = 61 postinjection).
3 (111)In-IMP288 (9.1 +/- 2.8% ID/g at 2 hours postinjection).
4 % injected dose per gram of tissue at 30 min postinjection.
5 P to flu (PSMA-PC3) ratio of 44:1 at 120 min postinjection.
6 5 h) reached a maximum of 28.0% ID/g at 12 h postinjection.
7 tter than that of 99mTc-Sestamibi at 120 min postinjection.
8 stration of purified Stx2 and peaked at 48 h postinjection.
9 ing mice administered with 64Cu-L1 as 30 min postinjection.
10 measurement of food intake at 1, 2, and 4 h postinjection.
11 erved effects were relatively small at 0.5 h postinjection.
12 Mice were killed 3, 8, or 22 days postinjection.
13 d peak uptake being achieved in about 55 min postinjection.
14 quent food intake was measured 1, 2, and 4 h postinjection.
15 and best tumor/background contrast after 4 h postinjection.
16 respectively, of that accumulated at 8 hours postinjection.
17 W/cm2 for 2.5 h (lambda(max) 665 nm) at 24 h postinjection.
18 formed from 3 hours preinjection to 24 hours postinjection.
19 .2% ID/g) and the kidneys (4.8% ID/g) at 4 h postinjection.
20 rocessed for Fos immunohistochemistry at 1 h postinjection.
21 r tamoxifen and euthanized at 12 or 24 weeks postinjection.
22 levels of AMMN-derived O(6)-mG at 4 and 96 h postinjection.
23 kedly from 40% at 1 month to <5% by 3 months postinjection.
24 fold increase in liver MnSOD activity 7 days postinjection.
25 le and food intake was measured 1, 2 and 4 h postinjection.
26 not increase food intake over the first 4 h postinjection.
27 ice failed to develop scrapie up to 503 days postinjection.
28 5-Se/g of tumor was found at 3, 6, and 24 h postinjection.
29 n the first 24 hours, which abated by 7 days postinjection.
30 detected by immunohistochemistry up to 2 wk postinjection.
31 pectively, 30% and 10% of that recovered 1 h postinjection.
32 ed with the parental chTNT-3 6, 12, and 24 h postinjection.
33 in the MPO by 55 +/- 6% (P < 0.0001) at 1 h postinjection.
34 n, starting on days 1-3 and peaking on day 7 postinjection.
35 ocyte-specific PDE5 overexpression at 30 min postinjection.
36 mes higher than the other derivatives at 4 h postinjection.
37 ed in the eyes of control animals at 6 weeks postinjection.
38 rmTPO) intravenously and were killed 3 hours postinjection.
39 biopsy was performed 1.5-6 hr (mean = 3 hr) postinjection.
40 um-to-occipital ratio (SOR) of 3.5 at 90 min postinjection.
41 were then killed at 6, 24, 48, 96 and 168 hr postinjection.
42 (SPECT) images were obtained 14 to 20 hours postinjection.
43 amount of radioactivity (1.54% ID/g) at 24 h postinjection.
44 -[125I]IPBS was observed (7.40% ID/g) at 1 h postinjection.
45 tion of NPY and food intake was measured 1 h postinjection.
46 etect mRNAs for several cytokines at 3 hours postinjection.
47 ining in 0.25% of hepatocytes 8 to 10 months postinjection.
48 the donor-type human cells recovered 9 weeks postinjection.
49 density of gephyrin clusters 19 and 35 days postinjection.
50 +/- 1.6% ID/g and 5.2% +/- 4.4% ID) at 4 hr postinjection.
51 s 2-5 min, 10-15 min, 30-45 min and 1-1.5 hr postinjection.
52 intervals (1-2, 1-2.5, 1.5-2.5 and 2-3 min) postinjection.
53 d significant contrast enhancement up to 4 h postinjection.
54 ated radioactivity was determined at 2 hours postinjection.
55 on Days 3 and 7 and between 4-6 and 8-10 wk postinjection.
56 3.0% ID/g with [125I]-Tyr4-bombesin at 4 hr postinjection.
57 o-blood (0.20% ID/g) ratio was 1:2 at 30 min postinjection.
58 cytometry at either 6 to 8 weeks or 6 months postinjection.
59 R) for both tracers at approximately 100 min postinjection.
60 ternal granule and molecular layers 4-6 days postinjection.
61 i neurons were clearly identified by 20 days postinjection.
62 creatic tumor tissue in vivo as early as 1 h postinjection.
63 er with pulse-like kinetics that peak at 3 h postinjection.
64 is limited owing to a changing concentration postinjection.
65 6% ID/g) among these (99m)Tc-peptides at 2 h postinjection.
66 [(18)F]5, and [(18)F]6, respectively, at 2 h postinjection.
67 ancement in signal in tumor-bearing mice 2 h postinjection.
68 ptomatic lesions were detected up to 5 years postinjection.
69 ssue showed moderate ALP activity at 13 days postinjection.
70 ation were performed at 24, 48, 72, and 96 h postinjection.
71 formed preinjection, and at 1, 2, and 4 days postinjection.
72 time course of events ranging from 1 to 21 d postinjection.
73 ht be important for both steroids at 1 month postinjection.
74 l resolution of organs as a function of time postinjection.
75 onstruct was only 5-10% of wild-type at 8 mo postinjection.
76 ained at baseline and at 2 weeks and 6 weeks postinjection.
77 aphy was done on other animals until 5 weeks postinjection.
78 with c(RGDyK) ( approximately 4%ID/g) 1 hour postinjection.
79 m of all S129A-treated rats as early as 4 wk postinjection.
80 , n=3, showed faster brain washout at 30 min postinjection (0.42 and 1.57% dose/g) as compared to the
81 served for the initial brain uptake at 2 min postinjection (0.50% and 0.28% dose/organ for 2A,B, resp
86 d PTX-RGD showed highest tumor uptake at 2 h postinjection (2.72 +/-0.16%ID/g) and best tumor/backgro
87 in vesicles beneath the cuticular plate 27 h postinjection; (2) the number of vesicles per hair cell
93 rong and specific uptake in AR42J tumors 4 h postinjection (9.3+/-1.6% ID/g vs 0.3+/-0.0% ID/g during
94 Axonal Guidance Signaling System." At 1 week postinjection a common theme was activation of genes exp
96 r injection, and time between injections and postinjection acquisitions were identical for both exami
97 were monitored rectally every 30 min for 3 h postinjection, after which, the animals were sacrificed.
104 d given a first bladder void break at 40 min postinjection and a second void at the end of study at 1
105 f the parabrachial nucleus at 6 and 24 hours postinjection and an ipsilateral decrease below basal le
107 tudies extended these analyses for 40 months postinjection and evaluated whether the longevity of tra
110 s detected in retinal vascular cells at 24 h postinjection and persisted until day 6 (the end point o
111 ted dose per gram (ID/g) was seen at 4 hours postinjection and remained at 5.91% ID/g at 24 hours, wi
112 produced high-contrast immuno-PET images 4 h postinjection and showed specific uptake in the spleen a
113 re found initially in white matter at 2 days postinjection and subsequently in the internal granule a
114 GH levels (15.0 +/- 2.4 ng/mL) at 40 minutes postinjection and tended to decrease fasting gastric vol
115 ols rose approximately 1 degrees C by 80 min postinjection and then gradually abated over the followi
116 peak tracer uptake in the brain within hours postinjection and to provide greater selectivity for the
117 ined from rabbit knee joints on days 3 and 7 postinjection and used for analysis of IGF-1 expression,
118 y in all these areas was present at 10 hours postinjection and was restricted to the areas undergoing
120 igh tumor uptake (31.4 +/- 10.8%ID/g at 36 h postinjection) and a tumor/muscle ratio of 76.4 +/- 52.3
121 (90% injected dose per gram of tissue at 2 h postinjection) and high tumor-to-organ ratios, [(18)F]23
122 ed radioligand present in blood up to 45 min postinjection, and gave a 37-fold greater prostate-to-bo
123 hrough the lungs and kidneys several seconds postinjection, and spleen and liver at slightly later ti
124 thin 16 hours ( approximately 50% depletion) postinjection, and the alpha-SMA+ stroma population was
125 ials onto abducens motoneurons within 2 days postinjection, and transmission remains blocked for at l
129 ntibiotics only, 0.06% among injections with postinjection antibiotics only, and 0.04% among injectio
132 light exposure of 135 J/cm2 (75 mW/cm2; 24 h postinjection) at 796 nm for 30 min produced a 60% long-
134 ose (0.1 nmol) during 30 minutes to 24 hours postinjection, because of partial self-inhibition of rec
136 ciception more rapidly (maximal effect at 1h postinjection) but also lose their analgesic activity fa
137 unoreactive clusters were observed at 5 days postinjection, but we found significant reductions (25-4
140 lization of the microsphere deposition, with postinjection CNR values (mean, 14.29 +/- 3.98 [standard
141 t all time points (30, 60, 120, 180, 240 min postinjection), colocalized Fos and Jun immunostaining w
142 ng PC3 tumors (12.4 +/- 3.7% ID/g at 2 hours postinjection), comparable with (111)In-IMP288 (9.1 +/-
143 Tc-P829 was high (4.1 and 4.9%ID/g at 90 min postinjection compared to 2.9% for 111In-[DTPA]octreotid
146 uscle injection site and draining lymph node postinjection, consistent with the rapid drainage of the
150 levels were found in the vitreous peaking at postinjection day 7, diminishing to baseline by postinje
151 nfluence feeding behavior for the first 3 hr postinjection, decreased food intake dose dependently by
152 Maximum accumulation occurred at 6 hours postinjection, demonstrating specific intratumoral probe
153 injection and evaluated at 1 day and 1 week postinjection did not show a decrease in either hypoxia
156 orhexidine was associated with a low rate of postinjection endophthalmitis and was well tolerated by
158 s caused outbreaks of sterile and infectious postinjection endophthalmitis in at least 3 countries du
160 of the injected dose (%ID) in tumor at 4 hr postinjection (equating to 5.2 +/- 1.5 %ID/g tumor; n =
161 alpha16 results in enhanced responses 6-12 h postinjection, followed by complete attenuation at 36 h.
162 of striatal uptake enabling imaging 14-24 hr postinjection for stable quantitative measures of dopami
167 mplex class II (monoclonal antibody OX-6) on postinjection hours 0, 2, 4 and 8 and days 1, 3, 7, 14 a
170 cted in tumor-bearing animals up to 6 months postinjection in association with the murine T-cell tumo
173 [18F]fluoromisonidazole (FMISO) at 2 and 4 h postinjection in C3H mice bearing KHTn tumors (130-430 m
175 lesion could be delineated as early as 8 hr postinjection in the 99MTc window, the best target-to-no
180 before injection vs 0.3 +/- 0.1 mu m/s, n=33 postinjection, intracellular concentration = 80 nM profi
181 At the peak of virus replication, at 4 days postinjection, intrahepatic markers of HBV replication w
182 se of acute virus replication, and at 4 days postinjection, it was reduced by nearly 2 logs in the ab
183 n-to-cerebellum ratio of ligand at 80-90 min postinjection, kinetic analysis of the binding potential
184 n-releasing hormone (TRH) receptor cRNA 48 h postinjection, larger Galpha16 and Galpha15 cRNA injecti
186 al irritation leading to death 30 to 63 days postinjection (median, 36.0 days, mean, 38.7); death occ
187 ssfully modified by our laboratory whereby a postinjection methylation reaction, rather than silylati
188 f injection showed the best response, with a postinjection MIO similar to that in age-matched control
189 XFM-guided injections were compared with postinjection MRI and with necropsy specimens obtained 2
191 tumor/muscle ratio of 120.2 +/- 44.4 at 36 h postinjection; n = 4) compared with each monospecific Fa
192 At early time points (15 and 30 minutes postinjection), nuclear and possibly cytoplasmic fluores
196 stabilities and biodistributions out to 1 h postinjection of 67/68Ga and 111In chelates of 4SS, 5SS,
199 uggest that SPECT imaging performed at 24 hr postinjection of [123I]beta-CIT permits calculation of r
203 Cryo(DeltaLRR Z/DeltaLRR Z) mice at 6 hours postinjection of MSU crystals compared with WT mice.
207 intratumoral retention (~85% ID/tumor 7 days postinjection) of the radionuclide, elicited a tumor gro
210 ol animals delivered at term 60 +/- 15 hours postinjection (p.i.), those administered with O111:B4 de
214 pain level, the mean differences in pre- and postinjection pain and preinjection pain and post-MR ima
215 gions; this ratio increased from 5 to 30 min postinjection, particularly for [(18)F]18a-d and [(18)F]
216 PVN) in fasted as well as fed rats at 10-min postinjection, particularly in the medial parvocellular
219 ly decreased over the following 20 h (4-24 h postinjection period) in the orexin A 3 nmol injected gr
224 d complexes showed fast blood clearance (2 h postinjection (pi): (111)In-S, 0.07 +/- 0.03% ID/g; (111
226 different etiologies, including endogenous, postinjection, post-cataract surgery, and other anterior
230 delayed compared with ICP (28 vs. 4 minutes postinjection), resulting in a dramatic translaminar pre
231 of epidermal biopsies taken at 1 to 2 weeks postinjection revealed that these MMP3-expressing Sp-1 l
233 nic MnCl(2), comparisons of preinjection and postinjection scans, and voxelwise statistical mapping.
237 in mixed with CD-cholesterol had, at 7 hours postinjection, significantly smaller erosions than eyes
238 y-eight whole-body PET studies acquired with postinjection singles transmission scans were analyzed.
240 th adhesion resolution-necessitating careful postinjection spectral-domain optical coherence tomograp
241 1 muL automatic internal sample injector, a postinjection splitter with 1:10 splitting ratio, and a
242 red by high concentrations of effector cells postinjection, such as induced by higher bacterial loads
243 se to spontaneous Cl- currents within 6-12 h postinjection, suggesting that the early spontaneous act
244 ed in both LN and spleens at all time points postinjection, suggesting that the vector alone affected
247 ors were exposed to light for 30 min at 24 h postinjection), the benzobacteriochlorins containing N-s
248 fically, in the preinjected group, at 15 min postinjection, the 125I-labeled anti-Tac dsFv levels in
250 hin the time interval between 95 and 115 min postinjection, the radioactivity retained in the kidneys
253 al vein thrombin in the canine model by 1 hr postinjection (thrombus-to-blood ratio of 4.4 and thromb
255 (3)H)retinol in all mice exhibited a peak at postinjection times of 1.5 or 4.5 hours, and by 48 hours
258 onic ages were killed at different intervals postinjection to follow postmitotic cells' positional ch
259 Tumors were excised between 5 and 55 min postinjection to quantify tracer uptake while arterial p
261 both acute RVP and sustained focal RVP (24 h postinjection) to a greater extent in diabetic rats comp
263 g povidone-iodine 5% alone in the absence of postinjection topical antibiotics does not appear to pro
267 era coincidence scanner that can be used for postinjection transmission scanning has been developed.
269 24, 48, 96, and 168 h for (177)Lu-NeoBOMB1) postinjection tumor and organ uptake was determined.
272 T scans were obtained at baseline and at all postinjection visits, and for patients with baseline FTM
275 to-normal brain uptake ratio at 55 to 95 min postinjection was 47.5 for [11C]TPMP and 8.1 for [68Ga]E
278 Radioactivity due to 18F-FPH at 130 min postinjection was highest in the thalamus and hypothalam
280 We showed that FKRP expression at 10 months postinjection was reduced by about 50% with a single shR
282 of ghrelin (2.83 +/- 0.13 pmol/ml at 60 min postinjection) was not significantly different from that
283 umor/blood and tumor/muscle ratios at 90 min postinjection were 6 and 33 for 99mTc-P587, 21 and 68 fo
284 , suggesting that the early events occurring postinjection were required for these elevated adaptive
285 etention of [11C]HED taken from 50 to 60 min postinjection were used to differentiate sympathetically
286 esponding tumor-to-background ratios at 4 hr postinjection were: tumor/blood = 409 +/- 195; tumor/mus
287 tected in cerebrospinal fluid (CSF) on day 4 postinjection, were variably present over the ensuing 17
289 versus 17.7 +/- 7.0% injected dose at 24 hr postinjection), whereas the uptake of all other organs r
290 e observed in the eyes for at least 24 weeks postinjection, whereas no photoreceptor cells remained i
291 c-D-Lys((125)I-IBA)-ReCCMSH(Arg(11)) at 24 h postinjection, whereas values of 4.3 and 2.0 were observ
292 D/g) within PSMA(+) PC-3 PIP tumor at 30 min postinjection, which persisted, with clear delineation o
293 (33)P-TFO accumulated in the liver at 30 min postinjection, which was significantly higher than that
294 sue (%ID/g) within PSMA+ PIP tumor at 30 min postinjection, while [(68)Ga]6 showed a 2 h PSMA+ PIP tu
295 gand 18a, this same ratio was 8.4 at 120 min postinjection, while compound 18c displayed a lower spec
296 ted very encouraging results as early as 1 h postinjection with high tumor uptake (14.33% +/- 2.11% I
297 wed 3% ID/g in LNCaP xenograft tumors at 1 h postinjection with tumor-to-blood and tumor-to-muscle ra
298 A-derived activity was in metabolites at 2 h postinjection, with 15% in metabolites by 4 h; comparabl
299 ed cells were observed for at least 6 months postinjection without evidence of cell loss or neural da
300 nograft/blood ratios, reaching 19:1 at 120 h postinjection Xenograft regression using single doses of
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。